[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100656519":3},{"organization":4,"outcomesModule":7,"designInfo":56,"detailedDescription":62,"studyPopulation":55,"armGroups":63,"interventions":76,"overallOfficials":86,"centralContacts":93,"locations":98,"responsibleParty":114,"collaborators":55,"id":116,"slug":117,"hasResults":118,"nctId":119,"briefTitle":120,"officialTitle":121,"acronym":55,"eligibilityCriteria":122,"healthyVolunteers":118,"sex":123,"minAge":124,"maxAge":125,"enrollmentInfo":126,"targetDuration":55,"studyType":129,"phases":130,"briefSummary":132,"conditions":133,"keywords":137,"overallStatus":144,"whyStopped":55,"lastUpdateSubmitDate":145,"lastUpdatePostDateStruct":146,"startDateStruct":149,"completionDateStruct":151,"leadSponsor":153,"locationsCount":154},{"fullName":5,"class":6},"High Institute of Sports and Physical Education of Kef","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":42,"otherOutcomes":55},[9,13,17,21,24,27,30,33,36,39],{"measure":10,"description":11,"timeFrame":12},"Body Mass Index (BMI)","BMI calculated as weight (kg) divided by height squared (m²)","Baseline and after the 16 weeks of the training intervention.",{"measure":14,"description":15,"timeFrame":16},"Body fat percentage","Bodyfat percentage determined from four skinfold sites (biceps, triceps, subscapular, and supra-iliac) using a calibrated Harpenden Skinfold Caliper. Measurements expressed as %.","Baseline and after the 16 weeks of the training intervention",{"measure":18,"description":19,"timeFrame":20},"Waist circumference","Measured at the narrowest point between the rib cage and iliac crest using a non-elastic tape measure. Measurements expressed in cm.","Baseline and after the 16 weeks of the training intervention.]",{"measure":22,"description":23,"timeFrame":16},"Hip circumference","Measured at the widest point of the hips using a non-elastic tape measure. Measurements expressed in cm.",{"measure":25,"description":26,"timeFrame":12},"Total Cholesterol","Plasma total cholesterol concentration (mg\u002FdL).",{"measure":28,"description":29,"timeFrame":16},"Triglycerides","Plasma triglyceride concentration (mg\u002FdL)",{"measure":31,"description":32,"timeFrame":16},"High-Density Lipoprotein (HDL) Cholesterol","Plasma HDL cholesterol concentration (mg\u002FdL)",{"measure":34,"description":35,"timeFrame":12},"Low-Density Lipoprotein (LDL) Cholesterol","Plasma LDL cholesterol concentration (mg\u002FdL)",{"measure":37,"description":38,"timeFrame":12},"6-Minute Walk Test (6MWT) Distance","Distance walked in 6 minutes on a 30-meter straight corridor",{"measure":40,"description":41,"timeFrame":16},"Menopause-specific quality-of-life score (MENQOL)","Menopause-specific quality of life will be assessed using the validated Arabic version of the 29-item Menopause-Specific Quality of Life Questionnaire (MENQOL). Higher scores indicate poorer quality of life.",[43,46,49,52],{"measure":44,"description":45,"timeFrame":16},"Fasting glucose","Fasting plasma glucose concentration (mmol\u002FL).",{"measure":47,"description":48,"timeFrame":16},"Blood Pressure (Systolic and Diastolic)","Measured using an automated arm cuff (Omron BP652)",{"measure":50,"description":51,"timeFrame":16},"Resting Heart Rate","Measured using automated device (Omron BP652)",{"measure":53,"description":54,"timeFrame":16},"Satisfaction with life","Global life satisfaction will be assessed using the validated Arabic version of the 5-item Satisfaction with Life Scale (SWLS). Each item is scored from 1 to 7, with a total score ranging from 5 to 35. Higher scores indicate greater satisfaction with life",null,{"allocation":57,"interventionModel":58,"interventionModelDescription":55,"primaryPurpose":59,"observationalModel":55,"timePerspective":55,"maskingInfo":60},"RANDOMIZED","PARALLEL","PREVENTION",{"masking":61,"maskingDescription":55,"whoMasked":55},"NONE","This study is designed to investigate the effects of a 16-week whole-body electromyostimulation (WB-EMS) program on body composition, cardiometabolic markers, functional capacity, quality of life, and satisfaction with life in overweight\u002Fobese postmenopausal women. A total of 30 overweight\u002Fobese postmenopausal women will be randomly allocated to either the whole-body electromyostimulation (WB-EMS) group (n=15) or the control group (n=15). Participants in both groups will participate in a 16-week supervised exercise program consisting of two sessions per week, with at least 48 hours between consecutive sessions.\n\nParticipants in the WB-EMS group will perform 20-minute exercise sessions while receiving whole-body electrical stimulation. WB-EMS will be delivered using bipolar electrical impulses at a frequency of 85 Hz and a pulse width of 350 μs, with an intermittent stimulation pattern of 4 seconds of stimulation followed by 4 seconds of rest. During the sessions, participants will perform dynamic resistance and functional exercises involving major muscle groups, including squats, lunges, upper-body pushing and pulling movements, and trunk exercises.\n\nThe control group will perform the same supervised exercise program without electrical stimulation. Exercise type, session duration, weekly frequency, intervention duration, supervision, and progression will be matched between groups to isolate the additional effects of WB-EMS.\n\nOutcomes will be assessed at baseline and after the 16-week intervention. The assessments will include body composition, systolic and diastolic blood pressure, resting heart rate, functional capacity assessed using the 6-minute walk test (6MWT), fasting blood glucose, and lipid profile \\[triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C)\\]. Quality of life and satisfaction with life will also be assessed using validated questionnaires.",[64,70],{"label":65,"type":66,"description":67,"interventionNames":68},"WB-EMS group","EXPERIMENTAL","Participants will participate in a 16-week supervised exercise program consisting of two sessions per week, with at least 48 hours between consecutive sessions. Each session will include 20 minutes of whole-body electromyostimulation (WB-EMS) combined with dynamic resistance and functional exercises involving major muscle groups, including squats, lunges, upper-body pushing and pulling movements, and trunk exercises. WB-EMS will be delivered using bipolar electrical impulses at a frequency of 85 Hz and a pulse width of 350 μs, with an intermittent stimulation pattern of 4 seconds of stimulation followed by 4 seconds of rest. Exercise type, session duration, weekly frequency, supervision, and progression will be standardized throughout the intervention.",[69],"Other: Whole-body electromyostimulation (WB-EMS) training",{"label":71,"type":72,"description":73,"interventionNames":74},"Control group","ACTIVE_COMPARATOR","Participants will participate in the same 16-week supervised exercise program consisting of two sessions per week, with at least 48 hours between consecutive sessions. Participants will perform the same dynamic resistance and functional exercises as the WB-EMS group, including squats, lunges, upper-body pushing and pulling movements, and trunk exercises, but without electrical stimulation. Exercise type, session duration, weekly frequency, supervision, and progression will be matched to those of the WB-EMS group.",[75],"Behavioral: Supervised exercise without whole-body electromyostimulation (WB-EMS)",[77,81],{"type":6,"name":78,"description":79,"armGroupLabels":80,"otherNames":55},"Whole-body electromyostimulation (WB-EMS) training","Participants will complete a 16-week supervised exercise program consisting of two sessions per week, with at least 48 hours between consecutive sessions. The WB-EMS group will perform 20-minute sessions while receiving bipolar electrical stimulation at 85 Hz with a pulse width of 350 μs, using an intermittent 4-second stimulation\u002F4-second rest pattern. Exercises will include squats, lunges, upper-body pushing and pulling movements, and trunk exercises targeting major muscle groups. Stimulation intensity will be individually adjusted according to participants' tolerance, with a target perceived intensity of approximately 5-7 on a 0-10 scale.",[65],{"type":82,"name":83,"description":84,"armGroupLabels":85,"otherNames":55},"BEHAVIORAL","Supervised exercise without whole-body electromyostimulation (WB-EMS)","The control group will perform the same exercise program without electrical stimulation. Exercise type, session duration, weekly frequency, intervention duration, supervision, and progression will be matched between groups to isolate the additional effect of WB-EMS.",[71],[87,91],{"name":88,"affiliation":89,"role":90},"Nejmeddine Ouerghi, Ph.D","Research Unit \"Sport Sciences, Health and Movement\"(UR22JS01) High Institute of Sport and Physical Education of Kef, University of Jendouba, 7100 Kef, Tunisia.","PRINCIPAL_INVESTIGATOR",{"name":92,"affiliation":89,"role":90},"Nejmeddine Ouerghi",[94],{"name":88,"role":95,"phone":96,"phoneExt":55,"email":97},"CONTACT","+21625300232","najm_ouerghi@hotmail.com",[99],{"facility":100,"status":55,"city":101,"state":102,"zip":103,"country":104,"countryCode":105,"cosmosGeoPoint":106,"geoPoint":111,"contacts":112},"High Institute of Sport and Physical Education of Kef, University of Jendouba Kef, Boulifa, Tunisia, 7100","Tunis","Boulifa","7100","Tunisia","TN",{"type":107,"coordinates":108},"Point",[109,110],10.16579,36.81897,{"lat":110,"lon":109},[113],{"name":88,"role":95,"phone":96,"phoneExt":55,"email":97},{"type":90,"investigatorFullName":92,"investigatorTitle":115,"investigatorAffiliation":5,"oldNameTitle":55,"oldOrganization":55},"Dr","100656519","effects-of-whole-body-electromyostimulation-in-overweightobese-postmenopausal-women-100656519",false,"NCT07826754","Effects of Whole-Body Electromyostimulation in Overweight\u002FObese Postmenopausal Women","Effects of a 16-Week Whole-Body Electromyostimulation Program on Cardiometabolic Markers, Functional Capacity, and Quality of Life in Overweight\u002FObese Postmenopausal Women: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Body mass index (BMI) ≥25 kg\u002Fm²\n* Age 48-60 years\n* Postmenopausal status, defined as amenorrhea for \\>12 consecutive months\n* Stable eating habits\n\nExclusion Criteria:\n\n* Any medical condition or contraindication that prevents participation in physical exercise\n* Cardiovascular diseases (hypertension or heart failure)\n* Metabolic or inflammatory disorders (uncontrolled diabetes mellitus or autoimmune diseases)","FEMALE","48 Years","60 Years",{"count":127,"type":128},30,"ESTIMATED","INTERVENTIONAL",[131],"NA","The goal of this randomized controlled trial is to investigate the effects of a 16-week whole-body electromyostimulation (WB-EMS) program on body composition, cardiometabolic health, functional capacity, quality of life, and satisfaction with life in overweight\u002Fobese postmenopausal women. The study will examine whether adding WB-EMS to a supervised exercise program results in greater improvements in these outcomes compared with the same exercise program performed without electrical stimulation.\n\nParticipants will be randomly allocated to either the WB-EMS group or the control group. Both groups will participate in a 16-week supervised exercise program consisting of two sessions per week, with at least 48 hours between consecutive sessions.\n\nParticipants in the WB-EMS group will perform supervised exercise sessions with whole-body electrical stimulation. WB-EMS will be delivered using bipolar electrical impulses at a frequency of 85 Hz and a pulse width of 350 μs, with an intermittent stimulation pattern of 4 seconds of stimulation followed by 4 seconds of rest. The exercise program will include dynamic resistance and functional exercises involving major muscle groups, including squats, lunges, upper-body pushing and pulling movements, and trunk exercises.\n\nThe control group will perform the same supervised exercise program without electrical stimulation. Exercise type, session duration, weekly frequency, intervention duration, supervision, and progression will be matched between groups to isolate the additional effects of WB-EMS.",[134,135,136],"Postmenopausal Women","Overweight","Obesity",[138,139,140,141,142,136,143],"Whole-body electromyostimulation (WB-EMS)","Postmenopausal women","Cardiometabolic health","Quality of life","Electromyostimulation","6-minute walk test","NOT_YET_RECRUITING","2026-09-17",{"date":147,"type":148},"2026-09-22","ACTUAL",{"date":150,"type":128},"2026-09-20",{"date":152,"type":128},"2027-01-27",{"name":5,"class":6},1]